Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $81.0100 (7.45%) ($72.7900 - $91.0000) on Thu. Mar. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.5% (three month average) | RSI | 47 | Latest Price | $81.0100(7.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.3% a day on average for past five trading days. | Weekly Trend | LGND declines -13.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) IWC(54%) XBI(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -2.75% in a week (0% probabilities). VIXM(-32%) VXX(-19%) TLT(-13%) UUP(-6%) SHY(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.75% (StdDev 5.5%) | Hourly BBV | 0 () | Intraday Trend | 10.3% | | | |
|
1 - 5 Day Possible Target | $58.39(-27.92%) | Resistance Level | $93.12 | 5 Day Moving Average | $76.06(6.51%) | 10 Day Moving Average | $84.85(-4.53%) | 20 Day Moving Average | $93.12(-13%) | To recent high | -25.7% | To recent low | 27.8% | Market Cap | $1.302b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |